Back to top

Image: Bigstock

Simulations Plus (SLP) Q3 Earnings & Revenues Beat Estimates

Read MoreHide Full Article

Simulations Plus’ (SLP - Free Report) third-quarter fiscal 2020 adjusted earnings of 20 cents per share beat the Zacks Consensus Estimate by 233.3% and increased 25% year over year.

Moreover, revenues of $12.3 million surpassed the consensus mark by 16.2% and increased 23.8% year over year. Organic revenue growth was 18%.

Software revenues accounted for 56% of the company’s total revenues, and grew 18% year over year to $6.8 million. Service revenues represented 44% of total revenues and grew 32% year over year to $5.5 million.

Simulations Plus stated that roughly 85% of software revenues and 47% of total revenues in the reported quarter were derived from software renewals, which have experienced no negative impact to date from the coronavirus outbreak.

Moreover, service backlog at the end of reported quarter was more than $12 million, representing more than three quarters’ estimated average service revenues.
 

Simulations Plus, Inc. Price, Consensus and EPS Surprise

Simulations Plus, Inc. Price, Consensus and EPS Surprise

Simulations Plus, Inc. price-consensus-eps-surprise-chart | Simulations Plus, Inc. Quote

 

However, the company witnessed difficulty in winning new business both in terms of new software licenses, especially in Asia, and new service business during the quarter due to disruption caused by the pandemic.

Segment Top-Line Details

Lancaster division revenues were up 12% year over year to $6.7 million. Markedly, 79% of these revenues were derived from renewals, 10% from new sale, and 11% from consulting services. In the company’s software business, renewal rates remained high at 88% on an account business and 94% on a fee basis. New licensing units grew by 10% year over year.

New regulatory services offering from Simulations Plus generated roughly $250,000 in bookings in the quarter under review. The company added 11 new commercial companies, including new licenses in the United States, Europe, Japan and Brazil. Simulation Plus is engaged in Lancaster in projects with 28 companies and seven funded collaborations.

Buffalo division revenues were up 20% year over year to $3 million. The company inked 33 contracts and initiated 18 new projects in the reported quarter. Overall, Simulations Plus has 64 active projects across 31 companies and 28 proposals outstanding with 24 different companies as of Jul 1.

DILIsym revenues increased 39% year over year to $1.9 million. DILIsym software and service projects represented approximately 55% of revenues. RENAsym model services represented 5%, IPF model services represented 22% and RENAsym grant service revenues represented 10%. Moreover, the heart-failure model contributed revenues of roughly 8%.

DILIsym has 13 active consulting projects and seven active consortium contracts currently.

Notably, Simulations Plus acquired Lixoft, the developer of the highly regarded monolix suite in modeling platform. It covers a wide range of data types and statistical features for population and PK/PD modeling that is widely used by academic, pharma and regulatory agencies.

The buyout expanded Simulations Plus’ footprint in Europe. Lixoft contributed $566,000 of revenues, up 15% year over year.

Operating Details

Gross margin in the quarter under review was 78.3%, up 170 basis points (bps) year over year. Software gross margin was 90% in this seasonally high revenue growth quarter. Moreover, service gross margin increased to 63% based on solid performance by Cognigen division.

Research & development (R&D) expenses as a percentage of revenues decreased 40 basis points (bps) on a year-over-year basis to 6.1%. However, selling, general & administrative (SG&A) expenses increased to 40.8% from 31.1% in the year-ago quarter.

SG&A expenses included $1.1 million in one-time transaction costs related to the Lixoft acquisition.

Total operating expenses as a percentage of revenues were 47% compared with 37.5% reported in the year-ago quarter

Non-GAAP operating income margin declined to 31.4% from 39.1% reported in the year-ago quarter.

Balance Sheet & Cash Flow

As of May 31, 2020, cash and cash equivalents were $7.4 million compared with $11.4 million as of Aug 31, 2019.

Simulations Plus established a $3.5 million line of credit with a commercial bank in the reported quarter. Under the terms of the two-year agreement, drawn amounts incur interest at prime rate or at a fixed rate based on LIBOR plus a 175 bps.

Moreover, Simulations Plus declared a cash dividend of 6 cents per share to ba paid out on Aug 3, 2020, to shareholders of record as of Jul 27, 2020.

Zacks Rank & Stocks to Consider

Currently, Simulations Plus has a Zacks Rank #3 (Hold).

Some better-ranked stocks in the broader computer & technology sector are Calix (CALX - Free Report) , SAP SE (SAP - Free Report) and CyberOptics (CYBE - Free Report) . While Calix sports a Zacks Rank #1 (Strong Buy), both SAP and CyberOptics carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
   
Calix, CyberOptics and SAP are scheduled to report their quarterly results on Jul 21, 23 and 27, respectively.






These Stocks Are Poised to Soar Past the Pandemic

The COVID-19 outbreak has shifted consumer behavior dramatically, and a handful of high-tech companies have stepped up to keep America running. Right now, investors in these companies have a shot at serious profits. For example, Zoom jumped 108.5% in less than 4 months while most other stocks were sinking.

Our research shows that 5 cutting-edge stocks could skyrocket from the exponential increase in demand for “stay at home” technologies. This could be one of the biggest buying opportunities of this decade, especially for those who get in early.

See the 5 high-tech stocks now>>


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


SAP SE (SAP) - free report >>

Calix, Inc (CALX) - free report >>

Simulations Plus, Inc. (SLP) - free report >>

CyberOptics Corporation (CYBE) - free report >>